Table 4.
Long-term outcomes according to dexmedetomidine status.
| Variable | Entire cohort | Adjusted HR | 95% CI | p value | Propensity-matched cohort | p value | ||
| DEX | Non-DEX | DEX | Non-DEX | |||||
| N = 889 | N = 495 | N = 462 | N = 462 | |||||
| 30-day mortality | 14 (1.57) | 21 (4.24) | 0.448 | 0.219–0.916 | 0.028 | 7 (1.51) | 18 (3.90) | 0.027 |
| 1-year mortality | 21 (2.36) | 33 (6.67) | 0.487 | 0.274–0.867 | 0.014 | 13 (2.81) | 26 (5.63) | 0.031 |
DEX, dexmedetomidine; HR, hazard ratio; CI, confidence interval.